David Altarac serves as Executive at Entasis Therapeutics Holdings Inc., where they oversee executive responsibilities. Since joining the company, David Altarac has executed 7 insider transactions totaling $12.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jul 11, 2022 involved selling 150,000 shares valued at $0.
David Altarac currently holds 167,572 shares of Entasis Therapeutics Holdings Inc. (ETTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Altarac has been a net seller of ETTX stock. They have purchased $0 and sold $12.0K worth of shares.
David Altarac's most recent insider trade was on Jul 11, 2022, when they sold 150,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $2.20 |
| Discretionary |
| Jan 18, 2022 | ETTX | $0 | Award | 125,000 | $N/A | Discretionary |
| Nov 2, 2021 | ETTX | $10.8K | Payment | 3,669 | $2.94 | Discretionary |
| Oct 19, 2021 | ETTX | $0 | Award | 25,000 | $N/A | Discretionary |
| Oct 19, 2021 | ETTX | $12.0K | Sale | 3,759 | $3.19 | Discretionary |
| Jan 15, 2021 | ETTX | $0 | Award | 25,000 | $N/A | Discretionary |